Scorpius Holdings Files 8-K for Other Events

TL;DR

SCPX filed an 8-K for 'Other Events' on 10/10/25.

AI Summary

Scorpius Holdings, Inc. filed an 8-K on October 21, 2025, reporting an event that occurred on October 10, 2025. The filing is categorized under 'Other Events' and does not specify any financial transactions or material changes in business operations.

Why It Matters

This 8-K filing indicates a regulatory disclosure by Scorpius Holdings, Inc. for an event on October 10, 2025, requiring public notification.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for 'Other Events' without immediate disclosed financial impact or significant operational changes.

Key Players & Entities

• Scorpius Holdings, Inc. (company) — Registrant
• October 10, 2025 (date) — Earliest event reported
• October 21, 2025 (date) — Filing date
• NightHawk Biosciences, Inc. (company) — Former company name
• HEAT BIOLOGICS, INC. (company) — Former company name

FAQ

Key Financial Figures

• $13,388,889 — aggregate original principal amount of $13,388,889, a non-convertible promissory note, dat
• $500,083 — any in the original principal amount of $500,083 and non-convertible secured promissory
• $7,389,083 — ny in the aggregate principal amount of $7,389,083 (collectively, the "Secured Notes"), wh
• $26,048,716 — ntly represent obligations in excess of $26,048,716, that by reason of multiple defaults un

Filing Documents

• scpx_8k.htm (8-K) — 23KB
• 0001079973-25-001626.txt ( ) — 180KB
• scpx-20251010.xsd (EX-101.SCH) — 3KB
• scpx-20251010_lab.xml (EX-101.LAB) — 33KB
• scpx-20251010_pre.xml (EX-101.PRE) — 22KB
• scpx_8k_htm.xml (XML) — 3KB

01. Other Events

Item 8.01. Other Events. On October 10, 2025, Scorpius Holdings, Inc., a Delaware corporation (the "Company"), received a Notice of Public Disposition under the Uniform Commercial Code (the "Notice") from the collateral agent (the "Collateral Agent") on behalf of the holders (the "Holders") of the senior secured convertible notes, dated as of December 6, 2024, issued by the Company in the aggregate original principal amount of $13,388,889, a non-convertible promissory note, dated as of September 30, 2025, issued by the Company in the original principal amount of $500,083 and non-convertible secured promissory notes issued by the Company in the aggregate principal amount of $7,389,083 (collectively, the "Secured Notes"), which Secured Notes, with all unpaid interest, fees and expenses due thereunder, currently represent obligations in excess of $26,048,716, that by reason of multiple defaults under the Secured Notes the Collateral Agent will sell all or portion of the collateral pledged by the Company and its subsidiaries to secure the loan, as determined by the Collateral Agent in its sole discretion, at a public sale to be conducted in-person at the offices of SC&H Capital, 11000 Broken Land Parkway, 5th Floor, Columbia, MD 21044, or, in the sole discretion of the Collateral Agent, remotely by Zoom or similar video platform, on November 12, 2025 starting at 10:00 a.m. (Eastern Time) (unless rescheduled at or prior to such sale). The collateral pledged to secure the Secured Notes consists of all personal property and assets of the Company and its subsidiaries, wherever located and whether now or hereafter existing and whether now owned or hereafter acquired, of every kind, nature and description, whether tangible or intangible, including the Company's 94% interest in the capital stock of Scorpius Biomanufacturing, Inc. and 100% interest in the capital stock of Skunkworx Bio, Inc.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: October 21, 2025 SCORPIUS HOLDINGS, INC. By: /s/ Jeffrey Wolf Name: Jeffrey Wolf Title: Chairman, President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR